#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Internal Medicine / 2018 - 10

Transient elastography – role in the assessment of the liver disease development

Czech version

Authors: Nikola Uzlová 1;  Nikola Mejzlíková 1;  Soňa Fraňková 2;  Pavla Libicherová 1;  David Nosek 1;  Ivan Rychlík 1
Authors‘ workplace: I. interní klinika 3. LF UK a FN Královské Vinohrady, Praha 1;  Klinika hepatogastroenterologie IKEM, Praha 2
Published in: Vnitř Lék 2018; 64(10): 916-922
Category:

Overview

Transient elastography, an examination based on the liver stiffness measurement, is a method validated for the non-invasive liver fibrosis staging. This method was recently successfully introduced into routine clinical practice. In accordance with the global- wide screening of viral hepatitis (chronic viral hepatitis type B and type C) and with the increasing effectiveness of antiviral therapy, as well as with the increasing prevalence of non-alcoholic fatty liver disease (NAFLD), the part of population requiring the care of hepatologists is certain to increase. Now more than ever we need a non-invasive, fast, safe, inexpensive and reliable method for evaluating patients with chronic liver disease. A new area of ​​use of elastography appears to be used to measure the stiffness of the spleen as a prediction of the presence of esophageal varices or the stiffness (or rather fibrosis) of transplanted kidneys. The aim of this review is to provide a comprehensive view of transient elastography, its principles, advantages and pitfalls, including its use in everyday clinical practice.

Key words:

cirrhosis – fibrosis – renal allograft – transient elastography

Sources
  1. Sandrin L, Oudry J, Bastard C et al. Non-Invasive Assessment of Liver Fibrosis by Vibration-Controlled Transient Elastography (Fibroscan®). Dostupné z WWW: <https://www.intechopen.com/books/liver-biopsy/non-invasive-assessment-of-liver-fibrosis-by-vibration-controlled-transient-elastography-fibroscan>.
  2. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29(12): 1705–1713.
  3. Boursier J, Zarski JP, de Ledinghen V et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies. Hepatology 2013; 57(3): 1182–1191. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.25993>.
  4. Tapper EB, Castera L, Afdhal NH. FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice. Clin Gastroenterol Hepatol 2015; 13(1): 27–36. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cgh.2014.04.039>.
  5. Fraquelli M, Rigamonti C, Casazza G et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56(7): 968–973. Dostupné z DOI: <http://dx.doi.org/10.1136/gut.2006.111302>.
  6. Castéra L, Foucher J, Bernard PH et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010; 51(3): 828–835. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.23425>.
  7. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49(4): 1083–1089. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.22748>.
  8. Boursier J, Zarski JP, de Ledinghen V et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013; 57(3): 1182–1191. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.25993>.
  9. Mederacke I, Wursthorn K, Kirschner J et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009; 29(10): 1500–1506. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1478–3231.2009.02100.x>.
  10. Berzigotti A, De Gottardi A, Vukotic R et al. Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS One 2013; 8(3): e58742. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0058742>.
  11. Arena U, Lupsor Platon M, Stasi C et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 2013; 58(1): 65–72. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.26343>.
  12. Friedrich-Rust M, Ong MF, Martens S et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134(4): 960–974. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2008.01.034>.
  13. de Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008; 32(6 Suppl 1): 58–67. Dostupné z DOI: <http://dx.doi.org/10.1016/S0399–8320(08)73994–0>.
  14. Pavlov CS, Casazza G, Nikolova D et al. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev 2015; 1: CD010542. Dostupné z DOI: <http://dx.doi.org/10.1002/14651858.CD010542.pub2>.
  15. Wong VW, Vergniol J, Wong GL et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51(2): 454–462. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.23312>.
  16. Chan HL, Wong GL, Choi PC et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16(1): 36–44. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365–2893.2008.01037.x>.
  17. Ehrmann J, Hůlek P. Hepatologie. 2. vyd. Grada: Praha 2014. EAN 24780214. ISBN 978–80–247–8021–4.
  18. Wong VW, Verginiol J, Wong GL et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51(2): 454–462. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.23312>.
  19. Myers, RP, Pomier-Layrargues G, Kirsch R et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012; 55(1): 199–208. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.24624>.
  20. Wong VW, Verginiol J, Wong GL et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012; 107(12): 1862–1871. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2012.331>.
  21. Trabut JB, Thépot V, Nalpas B et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res 2012; 36(8): 1407–1411. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1530–0277.2012.01737.x>.
  22. Corpechot C, Carrat F, Poujol-Robert A et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012; 56(1): 198–208. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.25599>.
  23. de Franchis R. [Baveno VI Faculty]. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63(3): 743–752. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2015.05.022>.
  24. Stefanescu H, Grigorescu M, Luspor M et al. Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients, J Gastroenterol Hepatol 2011; 26(1): 164–170. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1440–1746.2010.06325.x>.
  25. Bureau C, Metivier S, Peron JM et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27(12): 1261–1268. Dostupné z DOI: <http://dx.doi.oerg/10.1111/j.1365–2036.2008.03701.x>.
  26. Kim SU, Lee JH, Kim DY et al. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012; 7(5): e36676. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0036676>.
  27. Sporea I, Raţiu I, Sirli R et al. Value of transient elastography for the prediction of variceal bleeding. World J Gastroenterol 2011; 17(17): 2206–2210. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v17.i17.2206>.
  28. Shi KQ, Fan YC, Pan ZZ et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int 2013; 33(1): 62–71. Dostupné z DOI: <http://dx.doi.org/10.1111/liv.12003>.
  29. Adler M, Larocca L, Trovato FM et al. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study. HPB (Oxford) 2016; 18(8): 678–683. Dostupné z DOI: <http://dx.doi.org/10.1016/j.hpb.2016.05.005>.
  30. Hezode C, Castera L, Roudot-Thoraval F et al. Liver stiffness diminishes with antiviral response in chronic hepatitis C. Aliment Pharmacol Ther 2011; 34(6): 656–663. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365–2036.2011.04765.x>.
  31. [European Association for the Study of the Liver]. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol 2017; 66(1): 153–194. Dostupné z DOI: Dostupné z DOI: <https://doi.org/10.1016/j.jhep.2016.09.001>.
  32. Kleiner DE, Brunt EM, Van Natta M et al. [Nonalcoholic Steatohepatitis Clinical Research Network]. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–1321. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.20701>.
  33. Arndt R, Schmidt S, Loddenkemper Ch et al. Noninvasive evaluation of renal allograft fibrosis by transient elastography – a pilot study. Transpl Int 2010; 23(9): 871–877. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1432–2277.2010.01057.x>.
  34. Sommerer C, Scharf M, Seitz Ch et al. Assessment of renal allograft fibrosis by transient elastography. Transpl Int 2013, 26(5): 545–551. Dostupné z DOI: <http://dx.doi.org/10.1111/tri.12073>.
Labels
Diabetology Endocrinology Internal medicine
Is functional dyspepsia really that frequent?
Does the time from symptoms onset to treatment impact further development of vein thrombosis in the leg?
Some causes of poor adherence to long-term statin therapy and their solution
Angiotensin-converting enzyme inhibitor-induced angioedema: epidemiology, pathogenesis and management
Obstructive sleep apnea and dyslipidemia
CD38 targeted treatment for multiple myeloma
Fatty pancreas disease: clinical impact
Treatment of polycythemia vera
Weber-Christian disease: a case report
Multiple neuroendocrine tumor of the small bowel: a case report and a review of literature
Article was published in

Internal Medicine

Issue 10
2018 Issue 10
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#